Coaching Package PT-141
$235.00
Quantity
Injection | 10mg | 30-Day Supply (If Prescribed)
Includes telehealth consult, custom dosing plan, and expert support.
This SynRx coaching package offers access to a licensed telehealth provider through our partner network (e.g., Qualiphy), paired with expert coaching and ongoing support. All prescriptions are issued only if medically appropriate following an independent medical consultation. If not approved, you’ll receive a full refund. We do not prescribe or sell medication directly. All prescriptions are filled by licensed U.S. compounding pharmacies.
PT-141, also known as Bremelanotide, is a melanocortin receptor agonist originally developed to treat sexual dysfunction in both men and women. Unlike medications that act on the vascular system (like PDE5 inhibitors such as Viagra), PT-141 targets the central nervous system, stimulating desire and arousal at the brain level.
This makes it ideal for individuals experiencing low libido, performance issues, or arousal difficulties related to stress, hormonal imbalance, or psychological factors.
Activates melanocortin receptors (MC3R and MC4R) in the brain
Stimulates the hypothalamus, triggering sexual arousal
Increases dopamine, which is linked to desire and pleasure
Works independently of nitric oxide or vascular health
🔥 Enhanced Libido – Increases sexual desire in both men and women 💑 Improved Arousal & Sensation – Stimulates central arousal pathways for better experience 🕓 On-Demand Performance – Typically active within 30–60 minutes, lasting up to 12 hours 🌙 Supports Psychological Wellness – May benefit individuals with low desire due to anxiety or stress 🌿 Hormone-Free Option – No estrogen/testosterone or systemic hormone stimulation involved
Form: Sterile compounded injectable solution
Active Ingredient: PT-141 (Bremelanotide)
Administration: Subcutaneous injection (as needed, max 3x weekly)
Supply: 10mg per vial | 30-day supply
Storage: Refrigerate after reconstitution
Purity: ≥99% pharmaceutical-grade
Fulfillment: Licensed U.S. compounding pharmacy
Dosing Protocol: Personalized by your prescribing provider
✅ Expert-led dosing & accountability ✅ U.S. licensed providers & pharmacies only ✅ No “research use only” or grey-market peptides ✅ Focused on long-term wellness, not just short-term fixes ✅ 100% compliant with HIPAA and telehealth regulations
Clayton AH, et al. “Bremelanotide treatment for hypoactive sexual desire disorder.” Journal of Sexual Medicine (2016)
Kingsberg SA, et al. “Central mechanisms of action of PT-141 in female sexual arousal.” Hormones and Behavior (2014)
Shadiack AM, et al. “PT-141: A novel melanocortin agonist for the treatment of sexual dysfunction.” Peptides (2007)
Important Note: PT-141 is a prescription-only peptide therapy and must be used under the supervision of a licensed medical provider. Use only as directed, and follow your provider's dosing plan for safety and optimal results.
Peptide Therapy Disclaimer
Although our partner pharmacies use only FDA-approved ingredients that are pharmaceutical-grade and highly regulated, compounded prescriptions are not FDA approved
This website and any content provided herein are for informational and educational purposes only.
We are not a medical provider. All medications, including peptide therapies, are prescribed and managed exclusively by licensed medical professionals through a third-party medical group, Qualiphy PC. Any medical evaluations, diagnoses, prescriptions, or treatment decisions are made solely by those providers following a telehealth consultation and in accordance with applicable state and federal laws.
Our role is to support clients with non-medical coaching services such as fitness guidance, nutrition planning, and lifestyle accountability. We do not diagnose, treat, or prescribe medications. We are not responsible for the outcomes or effects of any medical treatment prescribed by third-party providers.
Always consult with a licensed healthcare provider before starting or stopping any medical treatment. If you have questions or concerns related to your medication, please contact the prescribing provider.